Biosimilars in Oncology – Sandoz and Amgen are Main Players in the Development of Biosimilars in Oncology

Posted on by

DUBLIN, Jan. 22, 2024 /PRNewswire/ — The “Thematic Intelligence – Biosimilars in oncology” report has been added to ResearchAndMarkets.com’s offering. The report provides an insight into the percentage of cancer patients treated with biosimilars, the price of these agents compared to…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.